In the same way, CX3CL1 expression was higher in U87w lysates in BBB models with PBMCs from controls patients (11.93-fold), mild AD patients (11.92-fold) and moderate AD patients (10.81-fold) (Table 3). This evidence concerns the gene CX3CL1 and Alzheimer disease.